Bioxytran, Inc.
BIXT
$0.1567
-$0.0054-3.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -503.60K | -401.10K | -661.70K | -800.30K | -1.03M |
| Total Depreciation and Amortization | 2.90K | 1.50K | 1.50K | 2.00K | 3.80K |
| Total Amortization of Deferred Charges | 622.80K | 25.00K | 30.00K | -- | 0.00 |
| Total Other Non-Cash Items | -170.10K | 52.20K | 66.50K | 450.50K | -215.10K |
| Change in Net Operating Assets | 92.10K | 352.60K | 509.20K | 272.20K | 1.15M |
| Cash from Operations | 44.10K | 30.20K | -54.50K | -75.60K | -92.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.10K | -9.10K | -1.10K | -6.00K | -6.60K |
| Cash from Investing | -12.10K | -9.10K | -1.10K | -6.00K | -6.60K |
| Total Debt Issued | -61.50K | 0.00 | 0.00 | 61.50K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 59.00K | 4.00K | 45.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -61.50K | 0.00 | 59.00K | 65.50K | 45.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.50K | 21.20K | 3.50K | -16.10K | -54.20K |